Olympus, JP3201200007

Olympus schedules November 10 results, with Olympus stock at a 24.24 P/ E

Published on 10/15/2026 at 20:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-quarter revenue reached JPY 240.40 billion, up 16.40 percent year over year. Olympus stock costs EUR 9.84 on October 15, 2026 at 8:00 p.m. CEST.

Olympus keeps results on calendar

Olympus will announce fiscal 2027 second-quarter results on November 10, 2026.
Fiscal 2027 first-quarter revenue reached JPY 240.40 billion, up 16.40 percent year over year.
Olympus stock was at EUR 9.84 at Lang & Schwarz on October 15, 2026 at 8:00 p.m. CEST.
Olympus traded at a P/E ratio of 24.24 on October 15, 2026.

Olympus, JP3201200007, Illustration mit AI erstellt.

Olympus will announce its fiscal 2027 second-quarter results on November 10, 2026, at approximately 3:30 p.m. JST, according to Olympus. That date gives investors the next fixed checkpoint after the medical-device maker reported strong first-quarter growth. At Lang & Schwarz, Olympus was at EUR 9.84 on October 15, 2026 at 8:00 p.m. CEST.

First-quarter revenue reached JPY 240.40 billion

For the first quarter of fiscal 2027, revenue rose 16.40 percent year over year to JPY 240.40 billion. Operating profit reached JPY 29.00 billion, up 74.40 percent from the comparable period, while adjusted operating profit increased 132.60 percent to JPY 30.70 billion, according to note.com. The adjusted operating profit margin was 12.80 percent, compared with 6.40 percent a year earlier.

Olympus stock stays inside its yearly range

The Tokyo-listed stock last stood at JPY 1,721 on October 15, 2026 at 3:30 p.m. JST, down 2.16 percent from JPY 1,759. Its session range was JPY 1,693.00 to JPY 1,764.00, with volume of 8,050,200 shares. The 52-week range runs from JPY 1,302.50 to JPY 2,210.50, placing the latest Tokyo price 22.43 percent above the low and 22.15 percent below the high.

Valuation meets a November reporting date

Olympus had a market capitalization of JPY 1.8 trillion and a P/E ratio of 24.24 on October 15, 2026. The November 10 results date is the next scheduled corporate event listed by Olympus. The company operates in healthcare and medical devices, with endoscopy and therapeutic systems at the center of its business.

Comparison with peers

Olympus (Tokyo Stock Exchange, JPY): P/E 24.24, market capitalization JPY 1.8 trillion
Medtronic (NYSE, USD): up 1.53 percent, P/E 23.57, market capitalization USD 122.4 billion
Stryker (NYSE, USD): up 3.89 percent, P/E 30.32, market capitalization USD 112.2 billion

Price and scheduled results

The next results date matters because the first-quarter figures combined faster revenue growth with a sharp operating-profit increase. The October 15 Tokyo move, however, left the stock below its 52-week high and above its 52-week low, keeping the valuation discussion tied to execution in the next reporting period.

Olympus was trading at EUR 9.84 at Lang & Schwarz on October 15, 2026 at 8:00 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Olympus stock.